Correction to: Nature Medicine https://doi.org/10.1038/s41591-022-02003-x, published online 29 September 2022.
In the version of this article initially published, the competing interests section did not state that Paul Lin (The University of Texas MD Anderson Cancer Center) has an institutional financial conflict of interest with Takeda Pharmaceutical. The omission has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Y., Basar, R., Wang, G. et al. Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med 30, 906 (2024). https://doi.org/10.1038/s41591-023-02770-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02770-1